Zhujun Cao

2.4k total citations
40 papers, 518 citations indexed

About

Zhujun Cao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Zhujun Cao has authored 40 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 26 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Zhujun Cao's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (13 papers). Zhujun Cao is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (13 papers). Zhujun Cao collaborates with scholars based in China, Australia and United States. Zhujun Cao's co-authors include Qing Xie, Xiaogang Xiang, Shisan Bao, Hui Wang, Yuhan Liu, Wei Cai, Yumin Xu, Ziqiang Li, Jie Lu and Gangde Zhao and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Hepatology.

In The Last Decade

Zhujun Cao

37 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhujun Cao China 14 379 289 69 68 62 40 518
Shumei Lin China 14 308 0.8× 270 0.9× 86 1.2× 51 0.8× 73 1.2× 39 506
Yuki Haga Japan 14 326 0.9× 284 1.0× 119 1.7× 37 0.5× 60 1.0× 48 586
Ruidong Mo China 9 263 0.7× 179 0.6× 49 0.7× 49 0.7× 84 1.4× 15 392
Gangde Zhao China 12 267 0.7× 211 0.7× 34 0.5× 40 0.6× 63 1.0× 28 363
Miguel Eugenio Zoubek Spain 9 168 0.4× 156 0.5× 104 1.5× 42 0.6× 35 0.6× 10 381
X Volkmann Germany 7 312 0.8× 236 0.8× 148 2.1× 82 1.2× 51 0.8× 7 503
Satoshi Tsunematsu Japan 14 190 0.5× 193 0.7× 126 1.8× 52 0.8× 45 0.7× 35 435
Jinghang Xu China 10 298 0.8× 223 0.8× 123 1.8× 33 0.5× 42 0.7× 38 452
Weimin She China 11 302 0.8× 183 0.6× 136 2.0× 58 0.9× 230 3.7× 14 585
Daxian Wu China 10 179 0.5× 123 0.4× 87 1.3× 47 0.7× 25 0.4× 25 325

Countries citing papers authored by Zhujun Cao

Since Specialization
Citations

This map shows the geographic impact of Zhujun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhujun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhujun Cao more than expected).

Fields of papers citing papers by Zhujun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhujun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhujun Cao. The network helps show where Zhujun Cao may publish in the future.

Co-authorship network of co-authors of Zhujun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhujun Cao. A scholar is included among the top collaborators of Zhujun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhujun Cao. Zhujun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carter, Glen P., Benjamin P. Howden, Tsai‐Wei Huang, et al.. (2025). Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin. Nature Communications. 17(1). 674–674.
2.
Yeo, Yee Hui, Mingjie Zhang, Juan Li, et al.. (2025). Predictive machine learning model in intensive care unit patients with acute-on-chronic liver failure and two or more organ failures. Clinical and Molecular Hepatology. 31(4). 1355–1371.
3.
Lu, Jie, Qing Li, Ziqiang Li, et al.. (2025). Heterogeneity in the seroprevalence of hepatitis E virus among hospital attendees: a retrospective study in Shanghai, China. Infectious Diseases. 57(7). 647–657.
4.
Cao, Zhujun, Yuhan Liu, Haiguang Xin, et al.. (2024). Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis. Journal of Hepatology. 82(5). 836–850. 3 indexed citations
5.
Cao, Zhujun, Florence Wong, Ashok Choudhury, et al.. (2024). Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. ˜The œLancet. Gastroenterology & hepatology. 9(11). 997–1009. 11 indexed citations
6.
Liu, Kehui, Zhujun Cao, Xiaoyin Wang, et al.. (2024). Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis. Hepatology International. 18(5). 1528–1539. 5 indexed citations
7.
Cao, Qiuyu, Yi Ding, Yu Xu, et al.. (2023). Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116). Frontiers of Medicine. 17(6). 1068–1079. 7 indexed citations
8.
Huang, Yan, et al.. (2023). Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone. Journal of Viral Hepatitis. 30(10). 803–809. 8 indexed citations
9.
10.
Cao, Zhujun, Xiaoyin Wang, Kehui Liu, et al.. (2023). The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB. Frontiers in Pharmacology. 14. 1164309–1164309. 9 indexed citations
11.
Huang, Yan, et al.. (2022). qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–7. 2 indexed citations
12.
Cao, Zhujun, Zi-Ke Sheng, Xiaogang Xiang, et al.. (2022). COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status. Infectious Diseases of Poverty. 11(1). 56–56. 12 indexed citations
13.
Huang, Yan, Rongtao Lai, Weijing Wang, et al.. (2022). Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. Frontiers in Cellular and Infection Microbiology. 11. 733348–733348. 14 indexed citations
14.
Ren, Peipei, Hu Li, Yan Huang, et al.. (2021). A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China. Antiviral Research. 194. 105163–105163. 9 indexed citations
15.
Chen, Liwen, Zhujun Cao, Lei Yan, et al.. (2020). Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome. Frontiers in Physiology. 11. 526–526. 12 indexed citations
16.
Cao, Zhujun, Yuhan Liu, Chuanwu Zhu, et al.. (2020). Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study. World Journal of Gastroenterology. 26(6). 645–656. 10 indexed citations
17.
Xu, Yumin, Zhujun Cao, Ziqiang Li, et al.. (2019). Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response. Frontiers in Physiology. 10. 1503–1503. 16 indexed citations
18.
Xu, Yumin, Yuhan Liu, Zhujun Cao, et al.. (2019). Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study. Digestive and Liver Disease. 51(9). 1323–1329. 32 indexed citations
19.
Yan, Lei, Chuanwu Zhu, Jing Li, et al.. (2018). Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients. Infection and Drug Resistance. Volume 11. 2001–2009. 12 indexed citations
20.
Cao, Zhujun, Jing Li, Yun Wang, et al.. (2016). Serum hepatocyte apoptosis biomarker predicts the presence of significant histological lesion in chronic hepatitis B virus infection. Digestive and Liver Disease. 48(12). 1463–1470. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shumei Lin Breakdown of academic impact, for papers by Yuki Haga Breakdown of academic impact, for papers by Ruidong Mo Breakdown of academic impact, for papers by Gangde Zhao Breakdown of academic impact, for papers by Miguel Eugenio Zoubek Breakdown of academic impact, for papers by X Volkmann Breakdown of academic impact, for papers by Satoshi Tsunematsu Breakdown of academic impact, for papers by Jinghang Xu Breakdown of academic impact, for papers by Weimin She Breakdown of academic impact, for papers by Daxian Wu
Rankless by CCL
2026